1. A phase I, randomized, placebo‐controlled study of molnupiravir in healthy Japanese to support special approval in Japan to treat COVID‐19. Issue 11 (23rd September 2022) Authors: Nakamura, Keisuke; Fujimoto, Katsukuni; Hasegawa, Chihiro; Aoki, Ikuo; Yoshitsugu, Hiroyuki; Ugai, Hiroyuki; Yatsuzuka, Naoyoshi; Tanaka, Yoshiyuki; Furihata, Kenichi; Maas, Brian M.; Wickremasingha, Prachi K.; Duncan, Kelly E.; Iwamoto, Marian; Stoch, Selwyn A.; Uemura, Naoto Journal: Clinical and translational science Issue: Volume 15:Issue 11(2022) Page Start: 2697 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗